Plasma endothelin-1 level is related to renal function and smoking status but not to blood pressure: An epidemiological study

Journal of Hypertension

Volumn 22, Issue 4, 2004, Pages 713-718

  Hirai, Yuji ^a   Adachi, Hisashi ^a   Fujiura, Yoshihisa ^a   Hiratsuka, Akiko ^a   Enomoto, Mika ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endothelin; Epidemiology; Humans; Hypertension; Kidney; Smoking

Indexed keywords

CHOLESTEROL; ENDOTHELIN 1; HEMOGLOBIN A1C; NITROGEN; UREA;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; B SCAN; BLOOD PRESSURE REGULATION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; SEX DIFFERENCE; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; TUNICA MEDIA; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 2142806788     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200404000-00013     Document Type: Article

References (35)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Kobayashi M, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415.
2. Levin ER. Endothelins. N Engl J Med 1995; 333:356-363.
3. Schiffrin EL. Endothelin and endothelin antagonists in hypertension. J Hypertens 1998; 16:1891-1895.
4. Schiffrin EL. Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens 2001; 14:83S-89S.
5. Kon V, Yoshioka T, Fogo A, Ichikawa I. Glomerular actions of endothelin in vivo. J Clin Invest 1989; 83:1762-1767.
6. A receptor activation. Am J Physiol 1993; 264:R222-226.
7. Masaki T, Kimura S, Yanagisawa M, Goto K. Molecular and cellular mechanism of endothelin regulation. Implications for vascular function. Circulation 1991; 84:1457-1468.
8. Saito Y, Nakao K, Mukoyama M, Imura H. Increased plasma endothelin level in patients with essential hypertension. N Engl J Med 1990; 322:205.
9. Kohno M, Yasunari K, Murakawa K, Yokokawa K, Horio T, Fukui T, et al. Plasma immunoreactive endothelin in essential hypertension. Am J Med 1990; 88:614-618.
10. Saito Y, Nakao K, Mukoyama M, Shirakami G, Itoh H, Yamada T, et al. Application of monoclonal antibodies for endothelin to hypertensive research. Hypertension 1990; 15:734-738.
11. Davenport AP, Ashby MJ, Easton P, Ella S, Bedford J, et al. A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci 1990; 78:261-264.
12. Schiffrin EL, Thibault G. Plasma endothelin in human essential hypertension. Am J Hypertens 1991; 4:303-308.
13. Miyauchi T, Yanagisawa M, Iida K, Ajisaka K, Suzuki N, Fujino M, et al. Age- and sex-related variation of plasma endothelin-1 concentration in normal and hypertensive subjects. Am Heart J 1992; 123:1092-1093.
14. Shichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto S, et al. Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 1990; 15:493-496.
15. Ottosson-Seeberger A, Ahlborg G, Hemsen A, Lundberg JM, Alvestrand A. Hemodynamic effects of endothelin-1 and big endothelin-1 in chronic hemodialysis patients. J Am Soc Nephrol 1999; 10:1037-1044.
16. Kanno K, Hirata Y, Numano F, Emori T, Ohta K, Shichiri M, et al. Endothelin-1 and vasculitis. JAMA 1990; 264:2868.
17. Ihling C, Szombathy T, Bohrmann B, Brockhaus M, Schaefer HE, Loeffler BM. Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis. Circulation 2001; 104: 864-869.
18. Properzi G, Francavilla F, Bellini C, D'Abrizio P, Mangiacotti B, Ferri C, et al. Blood endothelin-1 levels before and after carotid endoarterectomy for atherosclerotic stenosis. Atherosclerosis 2001; 154:137-140.
19. Kiowski W, Sütsch G, Hunziker P, Müller P, Kim J, Oechslin E, et al. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 1995; 346:732-736.
20. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 1996; 384:353-355.
21. Pousset F, Isnard R, Lechat P, Kalotka H, Carayon G, Maistre G, et al. Prognostic value of plasma endothelin-1 in patients with chronic heart failure. Eur Heart J 1997; 18:254-258.
22. Ando K, Hirata Y, Shichiri M, Emori T, Marumo F. Presence of immunoreactive endothelin in human plasma. FEBS Lett 1989; 245:164-166.
23. SAS Institute. SAS/STAT Software: User's guide. Vol. 2 Version 6.0. 4th ed. Cary, NC: SAS Institute Inc.; 1990.
24. Haak T, Jungmann E, Raab C, Usadel KH. Elevated endothelin-1 levels after cigarette smoking. Metabolism 1994; 43:267-269.
25. Goerre S, Staehli C, Shaw S, Lüscher TF. Effect of cigarette smoking and nicotine on plasma endothelin-1 levels. J Cardiovasc Pharmacol 1995; 26:S236-238.
26. Cardillo C, Kilcoyne CM, Waclawiw M, Cannon III RO, Panza JA. Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension 1999; 33:753-758.
27. Krum H, Viskoper RJ, Lacourciere Y, Budde M, Charlon V. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigation. N Engl J Med 1998; 338:784-790.
28. Grubbs AL, Ergul A. A review of endothelin and hypertension in African-American individuals. Ethn Dis 2001; 11:741-748.
29. Hocher B, Thöne-Reineke C, Rohmeiss P, Schmager F, Slowinski T, Burst V, et al. Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest 1997; 99:1380-1389.
30. Karam H, Heudes D, Bruneval P, Gonzales MF, Löffler BM, Clozel M, et al. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Hypertension 1996; 28:379-385.
31. A receptor blockade prevents the progression of renal failure and hypertension in uraemic rats. Nephrol Dial Transplant 1999; 14:1881-1888.
32. Blann AD, Kirkpatrick U, Devine C, Naser S, McCollum CN. The influence of acute smoking on leucocytes, platelets and the endothelium. Atherosclerosis 1998; 141:133-139.
33. Lowe GDO. Why do smokers have higher plasma fibrinogen levels than non-smokers? Clin Sci 2001; 101:209-210.
34. Okada K, Nishida Y, Murakami H, Sugimoto I, Kosaka H, Morita H, et al. Role of endogenous endothelin in the development of graft arteriosclerosis in rat cardiac allografts: Antiproliterative effects of bosentan, a nonselective endothelin receptor antagonist. Circulation 1998; 97: 2346-2351.
35. Iwanaga Y, Kihara Y, Hasegawa K, Inagaki K, Yoneda T, Kaburagi S, et al. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats. Circulation 1998; 98:2065-2073.